RPRX vs UTHR: stock comparison and AI forecast
Royalty Pharma Plc (RPRX) and United Therapeutics Corp (UTHR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RPRX Royalty Pharma Plc
- Market Cap
- $28.94B
- P/E Ratio
- 47.3x
- Size
- large-cap
- AI Forecast
UTHR United Therapeutics Corp
- Price
- $565.72 -0.6% · 6M
- Market Cap
- $24.26B
- P/E Ratio
- 21.4x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- RPRX is 1.2 times larger than UTHR by market capitalization ($28.94B against $24.26B).
- UTHR trades at 21.4 times trailing earnings, RPRX at 47.2 times.
- UTHR turns 38.6% of its revenue into net income, against 25.7% for RPRX.
- RPRX carries 1.41 times debt per unit of equity, against 0.12 times for UTHR.
- RPRX yields 1.41% in dividends; UTHR pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RPRX | UTHR |
|---|---|---|
| Market Cap | $28.94B | $24.26B |
| P/E Ratio | 47.25x | 21.38x |
| P/B Ratio | 4.23x | 3.87x |
| Dividend Yield | 1.41% | – |
| EPS | $1.43 | $26.46 |
| Book Value/Share | $15.96 | $146.33 |
| Revenue/Share | $6.11 | $74.32 |
| FCF/Share | – | $20.22 |
Profitability & Margins
| Metric | RPRX | UTHR |
|---|---|---|
| ROE | 9.8% | 19.6% |
| ROA | 3.5% | 17.5% |
| ROIC | 8.2% | 20.6% |
| Gross Margin | – | 86.3% |
| Operating Margin | 57.1% | 41.5% |
| Net Margin | 25.7% | 38.6% |
| EBT Margin | 44.8% | 47.3% |
| Tax Rate | 0.0% | 18.4% |
Financial Health
| Metric | RPRX | UTHR |
|---|---|---|
| Current Ratio | 1.29x | 4.61x |
| Quick Ratio | – | 4.29x |
| D/E Ratio | 1.41x | 0.12x |
| Financial Leverage | 2.85x | 1.12x |
| Interest Coverage | 1.2x | 162.0x |
| Working Capital | $347M | $2.26B |
Cash Flow
| Metric | RPRX | UTHR |
|---|---|---|
| Operating Cash Flow | $2.96B | $1.43B |
| Free Cash Flow | – | $867M |
| Capital Spending | – | -$562M |
| OCF Growth YoY | 23.1% | -8.1% |
| FCF Growth YoY | – | -22.7% |
| FCF/Sales | – | 27.2% |
| CapEx/Sales | – | 17.6% |
Operational Efficiency
| Metric | RPRX | UTHR |
|---|---|---|
| Asset Turnover | 0.13x | 0.45x |
| Receivables Turnover | – | 9.1x |
| Inventory Turnover | – | 2.2x |
| Fixed Assets Turnover | – | 1.6x |
| Days Sales Outstanding | – | 40 days |
| Days Inventory | – | 169 days |
| Payables Period | – | 436 days |
| Cash Conversion Cycle | – | -227 days |
Income Statement
| Metric | RPRX | UTHR |
|---|---|---|
| Total Revenue | $2.62B | $3.19B |
| Operating Income | $1.50B | $1.32B |
| Net Income | $671M | $1.23B |
| R&D Expense | $251M | $703M |
| SG&A Expense | – | $728M |
| Cost of Goods Sold | – | $435M |
Dividend & Shareholder Information
| Metric | RPRX | UTHR |
|---|---|---|
| Dividends Per Share | $0.95 | – |
| Payout Ratio | 66.4% | – |
| Shares Outstanding | 428M | 43M |
| Net Income Growth | -12.2% | -3.2% |
| EPS Growth | 4.4% | 0.1% |
RPRX vs UTHR: stock comparison and AI forecast
Which is bigger, RPRX or UTHR?
RPRX is 1.2 times larger than UTHR by market capitalization ($28.94B against $24.26B).
Which is cheaper on earnings, RPRX or UTHR?
UTHR trades at 21.4 times trailing earnings, RPRX at 47.2 times.
Which one does Intratio's AI model rank higher, RPRX or UTHR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.